Sanofi, Cheplapharm plan partnership covering 20 mature medicines and three manufacturing sites

Verifying
  • Sanofi and Cheplapharm announced plans for a strategic partnership covering medicines and manufacturing sites.
  • Sanofi will receive a 26.4% equity stake in Cheplapharm.
  • The transaction is expected to be completed by the third quarter of 2027.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.